About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2025 Clareo Health. All rights reserved.

UNKNOWN

Immune Response to Vaccination Against Covid-19, a Follow up Study

CoVacc - Immune Response to Vaccination Against Covid-19, an Open Multicenter Phase IV Study

NCT04920357•Umeå University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Vaccination; InfectionCovid19

Interventions

Vaccination

Locations

5

Sweden

Locations (5)

Mälarsjukhuset

Eskilstuna, Sweden

Karlstad Central hospital

Karlstad, Sweden

Örebro University hospital

Örebro, Sweden

Östersund hospital

Östersund, Sweden

Umeå University hospital

Umeå, Sweden

Key Dates

Start Date

March 31, 2021

Primary Completion Date

March 31, 2022

Completion Date

December 31, 2024

Last Updated

June 9, 2021

Related Studies

The Effect of the Covid-19 Pandemic Among Operated Patients

NCT04525716

RECRUITINGPhase 3

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients

NCT03188796

Critical IllnessVitamin D Deficiency+1 more

RECRUITINGPhase 1

Covid-19 and Influenza Oral Vaccine Study

NCT06355232

covid19 InfectionInfluenza, Human

Conversations You Want About Corona Virus Disease (COVID-19)

NCT05191420

Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19

NCT04611243

Lung FunctionExercise Capacity+2 more

COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy

NCT04678193

View all related studies

Contacts

Clas Ahlm, Prof

CONTACT

+46-(0)70-3172965 clas.ahlm@umu.se

Mattias Forsell, Assoc Prof

CONTACT

+46-(0)73-0211221 mattias.forsell@umu.se

Sponsors

Lead Sponsor

Umeå University

Collaborators

Region Västerbotten
Värmland County Council, Sweden
Örebro Läns Landsting
Sormland County Council, Sweden
Region Jämtland Härjedalen

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 9, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions